| 发明名称 |
PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF CANCER |
| 摘要 |
The present invention relates to a pharmaceutical combination comprising a CDK inhibitor and at least one antioxidant enzyme inhibitor for use in the treatment of cancer. The present invention also relates to a method for the treatment of cancer comprising administering to a subject in need thereof, a therapeutically effective amount of a CDK inhibitor and a therapeutically effective amount of at least one antioxidant enzyme inhibitor. The pharmaceutical combination of the present invention exhibits synergistic effect when used in the treatment of cancer. |
| 申请公布号 |
US2017112809(A1) |
申请公布日期 |
2017.04.27 |
| 申请号 |
US201515313543 |
申请日期 |
2015.05.27 |
| 申请人 |
Piramal Enterprises Limited |
发明人 |
ORWAR Owe;SRINIVASA Sreesha;MISHRA Prabha |
| 分类号 |
A61K31/4025;A61K45/06;A61K33/36;A61K31/7135;A61K31/41 |
主分类号 |
A61K31/4025 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of treating cancer comprising administering to a subject in need thereof, a therapeutically effective amount of a cyclin-dependent kinase (CDK) inhibitor and a therapeutically effective amount of at least one antioxidant enzyme inhibitor. |
| 地址 |
Mumbai IN |
